IL10 and neoplasm: In addition, several DAMPs (e.g., HMGB1, S100A4, uric acid) can also enhance the expression of immunosuppressive mediators like interleukin (IL)-10 and indoleamine 2,3-dioxygenase (IDO) in stem cells, thereby inhibiting lymphocyte responses and contributing to tumor promotion (118).